Patent · US Active

2-benzyl-benzimidazole complement factor B inhibitors and uses thereof

US9676728B2 · kind B2 · utility

2Cited by

6References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Christopher M. Adams · Arlington, US
Takeru Ehara · Tsukuba, JP
Keith Jendza · Boston, US
Nan Ji · Arlington, US
Rajeshri Ganesh Karki · Somerville, US
Toshio Kawanami · Belmont, US
Nello Mainolfi · Belmont, US
James J. Powers · Waltham, US
Michael H. Serrano-Wu · Cambridge, US
Chun Zhang · Waltham, US

Key dates

Filing date	Oct 29, 2014
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Oct 29, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.